Brief: Amniotics Q2 EBITDA at SEK -6 Million
31/08/2023 07:09
Aug 31 (Reuters) - Amniotics Q2 EPS SEK -0.03. * Q2 EBITDA SEK -6 million * Q2 net income SEK -6.5 million
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan